Production and characterization of monoclonal antibodies against midgut of ixodid tick, Haemaphysalis longicornis

2003 ◽  
Vol 115 (4) ◽  
pp. 355-363 ◽  
Author(s):  
Mie Nakajima ◽  
Michi Kodama ◽  
Haruko Yanase ◽  
Toshihiko Iwanaga ◽  
Albert Mulenga ◽  
...  
2007 ◽  
Vol 37 (9) ◽  
pp. 911-922 ◽  
Author(s):  
M. Abdul Alim ◽  
Naotoshi Tsuji ◽  
Takeharu Miyoshi ◽  
M. Khyrul Islam ◽  
Xiaohong Huang ◽  
...  

2007 ◽  
Vol 37 (3-4) ◽  
pp. 383-392 ◽  
Author(s):  
Xiaohong Huang ◽  
Naotoshi Tsuji ◽  
Takeharu Miyoshi ◽  
Maki Motobu ◽  
M. Khyrul Islam ◽  
...  

FEBS Journal ◽  
2007 ◽  
Vol 274 (13) ◽  
pp. 3299-3312 ◽  
Author(s):  
Maki Motobu ◽  
Naotoshi Tsuji ◽  
Takeharu Miyoshi ◽  
Xiaohong Huang ◽  
M. K. Islam ◽  
...  

2007 ◽  
Vol 53 (2) ◽  
pp. 195-203 ◽  
Author(s):  
Takeharu Miyoshi ◽  
Naotoshi Tsuji ◽  
M. Khyrul Islam ◽  
Xiaohong Huang ◽  
Maki Motobu ◽  
...  

1998 ◽  
Vol 79 (01) ◽  
pp. 104-109 ◽  
Author(s):  
Osamu Takamiya

SummaryMurine monoclonal antibodies (designated hVII-B101/B1, hVIIDC2/D4 and hVII-DC6/3D8) directed against human factor VII (FVII) were prepared and characterized, with more extensive characterization of hVII-B101/B1 that did not bind reduced FVIIa. The immunoglobulin of the three monoclonal antibodies consisted of IgG1. These antibodies did not inhibit procoagulant activities of other vitamin K-dependent coagulation factors except FVII and did not cross-react with proteins in the immunoblotting test. hVII-DC2/D4 recognized the light chain after reduction of FVIIa with 2-mercaptoethanol, and hVIIDC6/3D8 the heavy chain. hVII-B101/B1 bound FVII without Ca2+, and possessed stronger affinity for FVII in the presence of Ca2+. The Kd for hVII-B101/B1 to FVII was 1.75 x 10–10 M in the presence of 5 mM CaCl2. The antibody inhibited the binding of FVII to tissue factor in the presence of Ca2+. hVII-B101/B1 also inhibited the activation of FX by the complex of FVIIa and tissue factor in the presence of Ca2+. Furthermore, immunoblotting revealed that hVII-B101/B1 reacted with non-reduced γ-carboxyglutaminic acid (Gla)-domainless-FVII and/or FVIIa. hVII-B101/B1 showed a similar pattern to that of non-reduced proteolytic fragments of FVII by trypsin with hVII-DC2/D4 on immunoblotting test. hVII-B101/B1 reacted differently with the FVII from the dysfunctional FVII variant, FVII Shinjo, which has a substitution of Gln for Arg at residue 79 in the first epidermal growth factor (1st EGF)-like domain (Takamiya O, et al. Haemosta 25, 89-97,1995) compared with normal FVII, when used as a solid phase-antibody for ELISA by the sandwich method. hVII-B101/B1 did not react with a series of short peptide sequences near position 79 in the first EGF-like domain on the solid-phase support for epitope scanning. These results suggested that the specific epitope of the antibody, hVII-B101/B1, was located in the three-dimensional structure near position 79 in the first EGF-like domain of human FVII.


Sign in / Sign up

Export Citation Format

Share Document